Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
AAYAM : AKGIM Journal of Management, suppl Special Issue on Emerging Business and Economic Challenges ; 12(2):186-191, 2022.
Artículo en Inglés | ProQuest Central | ID: covidwho-2260167

RESUMEN

Many people envisioned the year 2020 as significant. In the past, there was anticipation for VISION 2020, the agrarian target, sustainability goals, and much more. However, as 2020 came to an end, the only accomplishment anyone could claim is their own survival. The economy, financial goals, and marketing initiatives have all been destroyed. It was a unique period of experience. People were utterly disorganized. Nobody was so certain until the start of these actions. The anticipated marketing effects were completely gone. Therefore, it became important to evaluate how our proud marketing and consumer behaviour theories held up in the turbulent year. The popularity of the Engel-BlackwellMiniard Model of Consumer Behavior has been put to the test by researchers.

2.
BMJ Case Rep ; 14(3)2021 Mar 24.
Artículo en Inglés | MEDLINE | ID: covidwho-1388475

RESUMEN

SARS-CoV-2 infection has recently been related to a spectrum of hyper-inflammatory states in children. There is a striking similarity between these hyper-inflammatory states and Kawasaki disease (KD). We present an interesting case of KD recurrence in a 10-year-old child, who had previously developed KD at 4 years of age. His symptoms included fever, maculopapular rash and altered sensorium. Investigations showed noticeably elevated inflammatory markers, and an echocardiography revealed dilated coronary arteries. SARS-CoV-2 IgG antibodies were positive. The child responded dramatically to intravenous immunoglobulin and intravenous methylprednisolone. It is possible that SARS-CoV-2 infection triggered the recurrence of KD in this child who might have been genetically predisposed to KD.


Asunto(s)
COVID-19/complicaciones , Síndrome Mucocutáneo Linfonodular/etiología , Antiinflamatorios/uso terapéutico , Anticuerpos Antivirales/aislamiento & purificación , COVID-19/terapia , Niño , Ecocardiografía/métodos , Humanos , Inmunoglobulinas Intravenosas/administración & dosificación , Masculino , Metilprednisolona/uso terapéutico , Síndrome Mucocutáneo Linfonodular/terapia , Síndrome Mucocutáneo Linfonodular/virología , Recurrencia , SARS-CoV-2 , Resultado del Tratamiento
3.
Internal Auditor ; 77(4):19, 2020.
Artículo en Inglés | ProQuest Central | ID: covidwho-825325

RESUMEN

In response to the global financial crisis of 2008, the US government enacted regulatory reforms requiring banks to perform an in-depth review of the risks in their businesses. Among the regulations, banks had to conduct stress testing and scenario analysis each year. These tests involved performing a "what-if" analysis of how their balance sheets, net income, capital cushion, and other key financial metrics would evolve if an economic stress occurred. Since then, stress testing has helped banks greatly improve their skills at identifying, quantifying, and managing risks. That has enabled them to provision capital to absorb losses arising from systematic risk events. But stress testing isn't just for banks. The negative economic impact of the COVID-19 pandemic reveals the need for organizations to be prepared to respond to economic shocks. Organizations and audit functions in other industries can learn from the banks' processes to implement stress testing in their business.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA